Dyadic to report full year 2023 financial results and host conference call on thursday, march 28, 2024

Jupiter, fla., march 14, 2024 (globe newswire) -- dyadic international, inc. (“dyadic”, “we”, “us”, “our”, or the “company”) (nasdaq: dyai), a global biotechnology company focused building innovative microbial protein production platforms to address the growing demand for global protein bioproduction utilizing its advanced microbial platforms to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that it will report its financial results for the year ended 2023 and host a corporate update conference call on thursday, march 28, 2024.
DYAI Ratings Summary
DYAI Quant Ranking